Warren Buffett's Berkshire Trims BYD Stake to Under 5%
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
HC Wainwright analyst initiated coverage on AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering immunology therapeutics.AnaptysBio has a pipeline of checkpoint
The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
The race to develop oral weight loss medications is intensifying as companies like Roche Holdings AG (OTC:RHHBY), Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), and Pfizer Inc (NYSE:PFE) strive to create alternatives to injectable drugs.
Nasdaq, S&P, and Dow Advance as Biden Drops Out From the Presidential Race
Nvidia and Semis Follow Market Higher after Kamala Takes the Stage | Herd on Wall Street
Morning traders, Happy Monday, where the market is open and working properly following a blue screen filed Friday. Investors are pricing in the aftermath of the closest to election day step down of a presumptive nominee: Biden is out.
Why Is AI Robot Maker Richtech Robotics Stock Jumping Today?
Richtech Robotics Inc. (NASDAQ:RR) shares are trading higher after the company installed its advanced robotic beverage system, ADAM, at Ghost Kitchens International Inc. in Dawsonville, Georgia.This
Oppenheimer Outlined a Top Buy and Sell Idea for Each S&P Sector
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Here Are Big Pharma's Leading Blockbuster Makers
What to Expect in the Week Ahead (Google and Tesla Earnings; GDP and PCE Data)
This week, investors should keep an eye on earnings reports from several key players, including Google and Tesla. Key economic data to watch for will include the release of the first estimate of second-quarter gross domestic product and the Federal Reserve's preferred inflation measure for June.
Financials Dominate in Q2 as Wall Street Slides Amidst Concerns on Tech - Earnings Scorecard
US stocks closed with all three major indices falling, with the S&P Nasdaq index seeing its largest weekly decline in three months. Technology stocks weakened, with Tesla down more than 4%, Nvidia down more than 2%, and CrowdStrike down more than 11%.
Investors accelerated their escape from technology stocks, with stocks and bonds in Europe and the United States being hit hard for two days. This week, the S&P 500 and Nasdaq fell by about 2% and 3.7%, respectively. The Nasdaq stopped its six-week continuous rise, while the Dow and small-cap indices rose by 0.7% and 1.7%, respectively. Chip stocks fell more than 3% on Friday and nearly 9% for the week. Nvidia also fell more than 8.7% for the past three months, making it the worst performer. The "seven sisters of technology" all fell for the week, and cybersecurity leader Crowdstrike, which triggered a global technology outage, fell 11% on Friday, the worst in nearly two years. The VIX panic index rose more than 32% for the week.
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,500 Today
Republic Servs (NYSE:RSG) has outperformed the market over the past 10 years by 7.87% on an annualized basis producing an average annual return of 18.57%. Currently, Republic Servs has a market
Breaking Down T-Mobile US: 8 Analysts Share Their Views
8 analysts have shared their evaluations of T-Mobile US (NASDAQ:TMUS) during the recent three months, expressing a mix of bullish and bearish perspectives.In the table below, you'll find a summary
Catalyst Watch: Earnings Deluge, Farnborough Airshow, Paris Olympics, and Trump Talks Crypto
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
On Friday, China's National Medical Products Administration approved Eli Lilly And Co Tirzepatide for long-term weight management.
Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Thursday, major U.S. stock indices were down, with the Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03, the S&P 500 falling almost 0.8% to 5,544.59, and the Nasdaq decreasing 0.7% to 17,871.22.
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.
Top 10 S&P 500 Stocks Down More Than 5% From Last Week